210,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
105 °P sammeln
  • Gebundenes Buch

This book describes health impact concerns and technologies in place and in development, and offers steps leading to proposed solutions. It suggests ways to manage risks to meet challenges that include both private enterprise initiatives and public sector involvement. It proposes the type of controls needed to address pharmaceutical contamination, stressing bioreactors of particular types, augmented by the process modifications needed. The book covers the impact and changes needed at sites such as hospitals, pharmaceutical factories, waste treatment plants, water purification sites, farms, and households.…mehr

Produktbeschreibung
This book describes health impact concerns and technologies in place and in development, and offers steps leading to proposed solutions. It suggests ways to manage risks to meet challenges that include both private enterprise initiatives and public sector involvement. It proposes the type of controls needed to address pharmaceutical contamination, stressing bioreactors of particular types, augmented by the process modifications needed. The book covers the impact and changes needed at sites such as hospitals, pharmaceutical factories, waste treatment plants, water purification sites, farms, and households.
Autorenporträt
Walter E. Goldstein, PhD, PE, founded Goldstein Consulting Company in 1994. He founded and developed a forensic sciences DNA profiling laboratory at the University of Nevada-Las Vegas from 2003 to 2008. It was shortly after this that his first book for Taylor & Francis was published, Sick Building Syndrome and Related Illness: Prevention and Remediation of Mold Contamination. Dr. Goldstein holds a BS in chemical engineering from the Illinois Institute of Technology (1961), and an MS(1971) and PhD in chemical engineering from the University of Notre Dame (1973). He also holds an MBA from Michigan State University (1968).